Piro Lito, M.D. Ph.D. is a physician-scientist at Memorial Sloan Kettering Cancer Center in New York. After receiving a MD-PhD degree from Michigan State University, he trained in Internal Medicine at the Beth Israel Deaconess Medical Center at Harvard Medical School and in Medical Oncology at Memorial Sloan Kettering Cancer Center. He studies signaling pathways that regulate cancer growth with an emphasis on understanding and treating cancers driven by mutant KRAS. His work has been recognized with the Pew-Stewart Scholar in Cancer Research and the Damon Runyon Clinical Investigator awards. He is the recipient of the Seldin-Smith Award for Pioneering Research by the American Society for Clinical Investigation and the Trailblazer Prize for Clinician Scientists by the Foundation of the National Institutes of Health.
Further Activities to have a look at